Adipose derived mesenchymal stem cells and their role in management of kidney diseases

IF 0.2 Q4 UROLOGY & NEPHROLOGY

Journal of Renal Injury Prevention Pub Date : 2024-01-29 DOI:10.34172/jrip.2024.32244

F. Dadras, F. Khoshjou

引用次数: 0

Abstract

Kidney diseases are universal and researchers are trying to figure out how to manage them. Meanwhile, stem cells are a promising source of therapy that has been considered for various kinds of illnesses. Here, we are going to present the newest studies allocated to the role of adipose-derived stem cells in the management of kidney diseases (e.g. acute and chronic kidney diseases, diabetic nephropathy, and rejection). By searching in PubMed, 34 paper related to the topic were reviewed. Various diseases and pathophysiologic aspects of them have been considered in their presentation, as well. Route of injection, combination therapy, and scaffolds are among the other subjects.

查看原文本刊更多论文

脂肪间充质干细胞及其在治疗肾脏疾病中的作用

肾脏疾病是一种常见病，研究人员正试图找出治疗方法。同时，干细胞是一种很有前景的治疗来源，已被考虑用于治疗各种疾病。在此，我们将介绍有关脂肪来源干细胞在治疗肾脏疾病（如急性和慢性肾脏疾病、糖尿病肾病和排斥反应）中的作用的最新研究。通过在PubMed上搜索，我们查阅了34篇与该主题相关的论文。在介绍中还考虑了各种疾病及其病理生理学方面的问题。其他主题还包括注射途径、联合疗法和支架。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Journal of Renal Injury Prevention UROLOGY & NEPHROLOGY-

CiteScore

1.60

自引率

0.00%

发文量

期刊介绍： The Journal of Renal Injury Prevention (JRIP) is a quarterly peer-reviewed international journal devoted to the promotion of early diagnosis and prevention of renal diseases. It publishes in March, June, September and December of each year. It has pursued this aim through publishing editorials, original research articles, reviews, mini-reviews, commentaries, letters to the editor, hypothesis, case reports, epidemiology and prevention, news and views and renal biopsy teaching point. In this journal, particular emphasis is given to research, both experimental and clinical, aimed at protection/prevention of renal failure and modalities in the treatment of diabetic nephropathy. A further aim of this journal is to emphasize and strengthen the link between renal pathologists/nephropathologists and nephrologists. In addition, JRIP welcomes basic biomedical as well as pharmaceutical scientific research applied to clinical nephrology. Futuristic conceptual hypothesis that integrate various fields of acute kidney injury and renal tubular cell protection are encouraged to be submitted.